AX-2025-021014 · 5-Amino-1MQ · WXT lot WXT-2505-M3910

Section 1

Results

Measured against the index acceptance specification for the non-peptide adjuncts class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

Parameter	Method	Result	Unit	Index spec
Purity	RP-HPLC, 32 min gradient, 214 nm	97.95	% area	≥ 98.0	FAIL
Total impurities	RP-HPLC, sum of reported peaks	2.05	% area	≤ 2.0	FAIL
Largest single impurity	RP-HPLC — 5-nitro-1MQ (unreduced precursor, +30 Da)	1.29	% area	≤ 1.00	FAIL
Identity — theoretical monoisotopic mass	calculated from molecular formula	285.9967	Da	—	NOT TESTED
Identity — observed monoisotopic mass	LC-MS, high resolution (ESI-TOF/QTOF)	285.9963	Da	—	NOT TESTED
Mass accuracy	observed vs theoretical	-1.5	ppm	± 10	PASS
Total peptide content	by difference from the gravimetric mass balance	50.33	%w/w	—	NOT TESTED
Target-compound content	total peptide content × purity	49.30	%w/w	—	NOT TESTED
Gross fill (as weighed)	five-place balance, under nitrogen	214.00	mg	100 mg declared	NOT TESTED
Recovered target peptide	gross fill × target content	105.502	mg	100 mg claim	NOT TESTED
Recovery against label claim	recovered ÷ claim	105.5	%	90.0 – 110.0	PASS
Water content	Karl Fischer, coulometric, duplicate	3.13	%	≤ 10.0	PASS
Counter-ion (iodide)	anion-exchange ion chromatography	46.07	%	≤ 12.0	FAIL
Residual solvent + inorganic residue	estimated — see /methods/residual-solvents-q3c/	0.47	%	—	NOT TESTED
Endotoxin	not ordered on this submission	not determined	—	≤ 5.0	NOT TESTED
Sterility	not ordered on this submission	not determined	—	no growth	NOT TESTED
Appearance	visual, diffuse light, black and white background	White cake, partial shrinkage from vial wall	—	white to off-white intact cake	FAIL
Reconstitution clarity	reconstituted per submitter procedure	Faint haze, clearing on standing	—	clear, no visible particulates	FAIL
pH (reconstituted, 1 mg/mL)	potentiometric, two-point calibration	4.55	—	2.5 – 8.0	PASS
Retention time (observed)	RP-HPLC, 32 min gradient	5.87	min	5.75 ± 0.25 (normalised)	PASS
Peak asymmetry (10 % height)	Ph. Eur. 2.2.46	1.34	—	0.80 – 1.50	PASS
Plate count, main peak	N = 5.54 (t/w½)²	40,094	—	≥ 20,000	PASS
Resolution to nearest impurity	vs free iodide (counter-ion, by IC)	0.00	—	no index criterion	REPORTED

Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

Figure 1. RP-HPLC trace, 32 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 40,094, and skew follows the reported asymmetry factor of 1.34. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 1.29 % impurity against a 97.95 % main peak is a line two pixels tall; the main peak runs off-scale there by design.

#	Peak	RT	Area (µV·s)	% area	Δ mass (Da)
1	5-Amino-1MQ — main peak	5.87	4,760,674	97.95	—
2	5-nitro-1MQ (unreduced precursor, +30 Da)	6.60	62,698	1.29	+29.974
3	1-methylquinolinium (des-amino, −15 Da)	5.53	17,011	0.35	-15.011
4	8-amino regioisomer	6.10	13,609	0.28	0.000
5	free iodide (counter-ion, by IC)	5.87	6,318	0.13	0.000
Closure check — purity + Σ impurities				100.00	CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 285.9967 Da, computed from C10H11N2+ · I−. All ppm figures on this site are against monoisotopic values — see why that matters.

Figure 2. ESI charge-state envelope, high-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 285.9963 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.

Charge	Theoretical m/z	Observed m/z	Δ m/z	Rel. abundance (%)
1+	287.0040	287.0036	-0.0004	100.0

Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

Component	Determination	%w/w of cake
Water	Karl Fischer	3.13
Counter-ion (iodide)	ion chromatography	46.07
Residual solvent + inorganic residue	estimated	0.47
Total peptide content	by difference	50.33
Total		100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

Figure	Supplier COA	This report	Index note
Purity (% area)	98.65	97.95	divergence +0.14 pp vs batch median
Total impurities (% area)	1.35	2.05
Largest single impurity (% area)	not stated	1.29
Water (%)	1.4	3.13
Counter-ion (%)	not stated	46.07
Peptide content (%w/w)	not stated	50.33
Endotoxin (EU/mg)	not stated	not determined
Method stated on certificate	NO	—	no method section — the result cannot be reconciled against any other

Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance: Buyer-sourced
Evidentiary weight: Strongest available evidence in this index.
Chain of custody: Retail purchase → submitter (−20 °C, 24 d) → laboratory (courier, dry ice, 6 d) → assay.
Assay date: 24 Apr 2025
Submitted to the index: 14 May 2025
Laboratory: VendorInvestigate, Riga, Latvia
Method basis: 32 min gradient · high-resolution MS
Verification status: VERIFIED

What this report does not establish

That the material is free of bacterial endotoxin. Endotoxin was not measured. No chromatographic result bears on it.
That the material is sterile. Sterility was not tested.
That any other vial in the same lot has the same composition. One vial was tested. Within-lot vial-to-vial variation in this index has a median of 0.28 pp and a 90th percentile of 0.74 pp.
That any other lot from the same supplier has the same composition. Batch-to-batch variation is larger than within-batch variation for every supplier here.
That the material is suitable for administration to a human or an animal. These are research compounds. No result on this site is a safety assessment and the index takes no position on use.
That the material was manufactured by the supplier that sold it. Contract synthesis is normal in this market and twenty-nine batches in the index fingerprint to a bulk from a different company than the one named on the label.

Section 6

Annotations

No annotations on this record. Annotations are short signed technical comments from index contributors; see how to contribute.

Section 7

Related records

Same batch — lot WXT-2505-M3910 n=10

Report	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2025-021015	WXT-2505-M3910	Janoshik	2025-Q2	98.61	2.77	—	Supplier-supplied	1	FAIL
AX-2025-021016	WXT-2505-M3910	Janoshik	2025-Q2	98.43	2.83	—	Buyer-sourced	1	FAIL
AX-2025-021017	WXT-2505-M3910	Medutest	2025-Q2	98.61	2.51	—	Supplier-supplied	1	FAIL
AX-2025-021018	WXT-2505-M3910	Medutest	2025-Q2	98.29	2.58	—	Buyer-sourced	1	FAIL
AX-2025-021019	WXT-2505-M3910	Janoshik	2025-Q2	98.72	2.74	—	Supplier-supplied	1	FAIL
AX-2025-021020	WXT-2505-M3910	Nordanalyt	2025-Q2	98.58	2.88	—	Supplier-supplied	1	FAIL
AX-2025-021021	WXT-2505-M3910	Janoshik	2025-Q2	98.05	2.95	90.6	Buyer-sourced	2	FAIL
AX-2025-021022	WXT-2505-M3910	Janoshik	2025-Q2	97.99	2.71	100.3	Laboratory-retained	1	FAIL
AX-2025-021023	WXT-2505-M3910	Kestrel	2025-Q2	98.82	2.93	107.5	Supplier-supplied	1	FAIL

Batch rollup and reproducibility assessment →

Cross-sections

Other recent 5-Amino-1MQ records in the index.
Report	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-042753	GGPeps	GGPE-2512-M9695	Medutest	2026-Q2	99.21	4.61	93.5	Supplier-supplied	2	FAIL
AX-2026-042970	KP	KP-2511-W4792	Janoshik	2026-Q2	98.89	4.03	91.0	Supplier-supplied	2	FAIL
AX-2026-042969	KP	KP-2511-W4792	Janoshik	2026-Q2	99.33	3.94	—	Buyer-sourced	2	FAIL
AX-2026-042967	KP	KP-2511-W4792	Janoshik	2026-Q2	99.49	4.14	—	Supplier-supplied	2	FAIL
AX-2026-042754	GGPeps	GGPE-2512-M9695	PeptideMeter	2026-Q2	99.20	4.90	96.8	Supplier-supplied	2	FAIL
AX-2026-042971	KP	KP-2511-W4792	Janoshik	2026-Q2	99.45	4.19	107.1	Supplier-supplied	2	FAIL
AX-2026-042968	KP	KP-2511-W4792	Janoshik	2026-Q2	98.87	4.32	91.5	Buyer-sourced	2	FAIL
AX-2026-042012	TFC	TFC-2508-L6321	Janoshik	2026-Q1	99.93	5.84	95.7	Supplier-supplied	0	FAIL

Other recent WXT records in the index.
Report	Compound	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-043488	Pramlintide	WXT-2603-D6052	Janoshik	2026-Q3	97.87	4.37	—	Supplier-supplied	1	MARGINAL
AX-2026-043406	Semaglutide	WXT-2604-C4728	Janoshik	2026-Q3	97.24	4.65	—	Supplier-supplied	1	MARGINAL
AX-2026-043421	Sermorelin	WXT-2608-P4867	Janoshik	2026-Q3	98.15	3.09	—	Supplier-supplied	0	PASS
AX-2026-043420	Sermorelin	WXT-2608-P4867	Medutest	2026-Q3	98.62	3.07	96.4	Supplier-supplied	0	PASS
AX-2026-043423	Sermorelin	WXT-2608-P4867	Janoshik	2026-Q3	98.28	3.86	98.5	Buyer-sourced	0	PASS
AX-2026-043401	Semaglutide	WXT-2604-C4728	Medutest	2026-Q3	97.70	4.78	91.5	Supplier-supplied	1	MARGINAL
AX-2026-043400	Semaglutide	WXT-2604-C4728	Nordanalyt	2026-Q3	96.86	4.11	106.4	Laboratory-retained	1	FAIL
AX-2026-043422	Sermorelin	WXT-2608-P4867	Medutest	2026-Q3	98.35	3.59	—	Supplier-supplied	1	MARGINAL